X. Wang, Y. Chen, X. Zhang, Y. Chen, C. Tan, Y. Wang, J. Ding, L.-H. Meng and C. YangDiscovery of clinical candidate methyl (5-(6-((4(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo 2,1- f 1,2,4 triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) : A highly potent and selective PI3K alpha inhibitor for the treatment of advanced solid tumors

Pre One:Q.-L. Zhao, P.-J. Xia, J.-A. Xiao, Z.-P. Ye, X. Xie, H. Sheng, X.-Q. Chen and H. YangVisible-Light-Induced External Radical-Triggered Annulation To Access CF2-Containing Benzoxepine Derivatives

Next One:J. Li, Y.-L. Qian, Q.-L. Zhao, H.-Y. Xiang, J.-A. Xiao, X.-Q. Chen and H. YangSolvent-Minimized, Chromatography-Free, Diastereoselective Synthesis of Oxazolidine-Dispirooxindoles via oxa-1,3-Dipolar Cycloaddition of 3-Oxindole